US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock

Journal of Critical Care

Volumn 27, Issue 4, 2012, Pages 351-361

  Bruno, Jeffrey J ^a   Dee, Brian M ^a   Anderegg, Brent A ^a   Hernandez, Mike ^a   Pravinkumar, S Egbert ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adrenal insufficiency; Adrenocorticotropic hormone; Critical illness; Health care survey; Sepsis; Shock

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; MEPREDNISONE;

ARTICLE; CLINICAL PRACTICE; DELIRIUM; DISEASE SEVERITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; HEALTH CARE PERSONNEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; MEDICAL DECISION MAKING; MYOPATHY; NURSE; PHARMACIST; PHYSICIAN; PHYSICIAN ASSISTANT; POLYNEUROPATHY; PRESCRIPTION; SEPSIS; SEPTIC SHOCK; SUPERINFECTION; TREATMENT RESPONSE; UNITED STATES; WOUND DEHISCENCE;

ADRENAL CORTEX HORMONES; COSYNTROPIN; DECISION MAKING; HEALTH PERSONNEL; HEALTH STATUS; HUMANS; HYDROCORTISONE; PHYSICIAN'S PRACTICE PATTERNS; SEPSIS; SHOCK, SEPTIC; UNITED STATES;

EID: 84864125046     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.12.011     Document Type: Article

References (37)

1. Lefering R., Neugebauer E.A.M. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995, 23:1294-1303.
2. Cronin L., Cook D.J., Carlet J., et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995, 23:1430-1439.
3. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976, 184:333-339.
4. Sprung C.L., Caralis P.V., Marcial E.H., et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 1984, 311:1137-1143.
5. Bone R.C., Fisher C.J., Clemmer T.P., et al. A controlled trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317:653-658.
6. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987, 317:659-665. The Veterans Administration Systemic Sepsis Cooperative Study Group.
7. Briegel J., Schelling G., Haller M., et al. A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 1996, 22:894-899.
8. Annane D. Corticosteroids for septic shock. Crit Care Med 2001, 29:S117-S120.
9. Cooper M.S., Stewart P.M. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003, 348:727-734.
10. Marik P.E., Zaloga G.P. Adrenal insufficiency during septic shock. Crit Care Med 2003, 31:141-145.
11. Balk R.A. Steroids for septic shock: back from the dead? (pro). Chest 2003, 123:490S-499S.
12. Annane D., Maxime V., Ibrahim F., et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006, 174:1319-1326.
13. Lipiner-Friedman D., Sprung C.L., Francois Laterre P.F., et al. Adrenal function in sepsis: the retrospective CORTICUS cohort study. Crit Care Med 2007, 35:1012-1018.
14. Rothwell P.M., Udwadia Z.F., Lawler P.G. Cortisol response to corticotropin and survival in septic shock. Lancet 1991, 337:582-583.
15. Moran J.L., Chapman M.J., O'Fathartaigh M.S., et al. Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994, 20:489-495.
16. Bollaert P.E., Fieux F., Charpentier C., et al. Baseline cortisol levels, cortisol response to corticotropin, and prognosis in late septic shock. Shock 2003, 19:13-15.
17. Annane D., Sebille V., Troche G., et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000, 283:1038-1045.
18. Marik P.E., Pastores S.M., Annane D., et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36:1937-1949.
19. Bollaert P.E., Charpentier C., Levy B., et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26:645-650.
20. Briegel J., Forst H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999, 27:723-732.
21. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
22. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
23. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008, 36:296-327.
24. Bourne R.S., Webber S.J., Hutchinson S.P. Adrenal axis testing and corticosteroid replacement therapy in septic shock patients-local and national perspectives. Anaesthesia 2003, 58:571-596.
25. Confalonieri M., Urbino R., Potena A., et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005, 171:242-248.
26. Rinaldi S., Adembri C., Grechi S., et al. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med 2006, 34:2334-2339.
27. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009, 31:2362-2375.
28. Annane D., Bellissant E., Sebille V., et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998, 46:589-597.
29. Bellissant E., Annane D. Effect of hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther 2000, 68:293-303.
30. Oppert M., Schindler R., Husung C., et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005, 33:2457-2464.
31. Sligl W.I., Milner D.A., Sundar S., Mphatswe W., Majumdar R. Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infec Dis 2009, 49:93-101.
32. Hamrahian A.H., Oseni T.S., Arafah B.M. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004, 350:1629-1638.
33. Annane D., Cariou A., Maxime V., et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010, 303:341-348.
34. Ely E.W., Shintani A., Truman B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004, 291:1753-1762.
35. Gaudreau J.D., Gagnon P., Harel F., et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005, 23:6712-6718.
36. Watts G., Roberts B.L., Parsons R. Delirium in the intensive care unit: searching for causes and sources. Crit Care Resusc 2007, 9:26-29.
37. Patel R.P., Gambrell M., Speroff T., et al. Delirium and sedation in the intensive care unit: Survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 2009, 37:825-830.